Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Datametrex will be providing the 1copy™ COVID-19 qPCR Multi Kit to test crew members, onboard performers, technicians and stagehands
  • The testing will commence September 30th continuing into the first quarter of 2022
  • Datametrex AI Limited is a technology-focused company
  • Datametrex AI Limited (DM) opened trading at C$0.175 per share

Datametrex (DM) has entered into a COVID-19 testing service agreement for a cruise line operated by one of the world’s largest entertainment companies.

Datametrex will be providing the 1copy™ COVID-19 qPCR Multi Kit, that can identify the new variants of COVID-19, for use in testing officers, crew performers, directors, choreographers, audio technicians, stagehands, and costume technicians at the Toronto area rehearsal facility.

The testing will commence September 30th continuing into the first quarter of 2022 and will increase each month until the full entertainment operations are hired and trained.

Marshall Gunter, CEO of Datametrex commented on the agreement.

“This new testing service for the cruise industry gets our feet in a new revenue stream. When the pandemic hit in March 2020, cruise ships were particularly hit hard, which brought the industry to a halt worldwide stranding over 50 cruise lines and more than 270 ships. In an industry worth approximately $150 billion, and 1,177,000 jobs equaling $50.24 billion in wages and salaries, it is important to test crew regularly to minimize the threat of a shutdown again.”

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex AI Limited (DM) opened trading at C$0.175 per share.

More From The Market Herald

" Feel Foods (CSE:FEEL) receives DTC eligibility

Feel Foods (FEEL) has received Depository Trust Company (DTC) eligibility in the United States.

" Andlauer Healthcare Group (TSX:AND) completes $169M bought deal offering

Andlauer Healthcare Group Inc. (AND) and Andlauer Management Group Inc. completed a bought deal offering of 3.5 million subordinate voting shares (SVSs).

" Avricore (TSXV:AVCR) expands HealthTab to select Shoppers Drug Mart locations in BC

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

" Clearmind (CSE:CMND) signs development and supply agreement with Aragen Life Sciences

Clearmind Medicine (CMND) will work with Aragen Life Sciences to produce its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).